Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.6.2263

Association between the XRCC3 Thr241Met Polymorphism and Risk of Colorectal Cancer: a Meta Analysis of 5,193 Cases and 6,645 Controls  

Namazi, Abolfazl (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences and Health Services)
Abedinzadeh, Maryam (Department of Biology, Art and Sciences University)
Nourbaksh, Parisa (Department of Medical Immunology, Kermanshah University of Medical Sciences and Health Services)
Neamatzadeh, Hossein (Department of Medical Immunology, Kermanshah University of Medical Sciences and Health Services)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.6, 2015 , pp. 2263-2268 More about this Journal
Abstract
Background: Many studies have reported associations of the X-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism with colorectal cancer (CRC) risk, but the results remained controversial. Hence, we performed the present meta-analysis with different inheritance models. Materials and Methods: We searched the PubMed and Google scholar databases for studies relating to associations between XRCC3 Thr241Met polymorphism and risk of CRC. 16 studies with 5,193 cases and 6,645 controls were finally included into the meta-analysis. Results: We found that the XRCC3 Thr241Met polymorphism was associated with increased CRC risk only under a dominant genetic model (CC+CT vs. TT: OR 0.575, 95%CI 0.498-1.665, p<0.001, $P_{heterogeneity}=0.00$, $I^2=83%$). There was a significant association between XRCC3 Thr241Met polymorphism and CRC risk in Caucasian in the overall 8 studies under only in the heterozygote genetic model (CT vs. TT: OR=0.929, 95%CI =0.806-1.070, P=0.308, $P_{heterogeneity}=0.002$, $I^2=57%$). Four studies evaluated the XRCC3 Thr241Met polymorphism and CRC risk in Asians. Two genetic models of the XRCC3 polymorphism were significantly correlated with increasing risk in Asians (dominant model: CC+CT vs. TT: OR= 0.609, 95%CI=411-0.902, P=0.013, $P_{heterogeneity}=0.54$, $I^2=0.00%$; Allele model: C vs. T: OR=0.708, 95 %=CI 0.605-0.829, p=0.000, $P_{heterogeneity}=0.000$, $I^2=92%$). The sensitivity analysis suggested stability of this meta-analysis and no publication bias was detected. Conclusions: In conclusion, this meta-analysis indicates that XRCC3 Thr241Met shows an increased CRC risk, particularly in Asians rather than Caucasians.
Keywords
Colorectal cancer; XRCC3 Thr241Met; polymorphism; Caucasians; Asians;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 He XF, Wei W, Li JL, et al (2013). Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene, 523, 10-9.   DOI   ScienceOn
2 Higgins JP (2008). Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol, 37, 1158-60.   DOI
3 Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods, 11, 193-206.   DOI   ScienceOn
4 Improta G, Sgambato A, Bianchino G, et al (2008). Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res, 28, 2941-6.
5 Jemal A, Bray F, Center MM, Ferlay J, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
6 Jin MJ, Chen K, Song L, et al (2005). The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet, 163, 38-43.   DOI   ScienceOn
7 Gao CM, Ding JH, Li SP, et al (2014). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a case-control study in Jiangsu Province of China. Asian Pac J Cancer Prev, 14, 6613-8.
8 Krupa R, Sliwinski T, Wisniewska-Jarosinska M, et al (2011). Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study. Mol Biol Rep, 38, 2849-54.   DOI
9 Krupa R, Blasiak J (2004). An association of polymorphism of DNA repairs genes XRCC1 and XRCC3 with colorectal cancer. J Exp Clin Cancer Res, 23, 285-94.
10 Mahmoudi T, Karimi K, Arkani M, et al (2014). Parathyroid hormone gene rs6256 and calcium sensing receptor gene rs1801725 variants are not associated with susceptibility to colorectal cancer in Iran. Asian Pac J Cancer Prev, 15, 6035-9.   DOI
11 Moghtit FZ, Aberkane MS, Le Morvan V, et al (2014). No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study. Med Oncol, 31, 942.   DOI
12 Moreno V, Gemignani F, Landi S, et al (2014). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 12, 2101-8.
13 Mucha B, Przybylowska-Sygut K, Dziki AJ, et al (2013). Association of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population. Pol J Pathol, 64, 185-90.
14 Nissar S, Sameer AS, Lone TA, et al (2014). XRCC3 thr241met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study. Asian Pac J Cancer Prev, 15, 9621-5.   DOI
15 Liu L, Miao L, Ji G, , et al (2013). Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol Rep, 40, 3943-52.   DOI
16 Pardini B, Naccarati A, Novotny J, et al (2008). DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res, 638, 46-53.
17 Shizhong Han, Hong-Tao Zhang, Zhentian Wang, et al (2006). DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Human Genetics, 14, 1136-44.   DOI
18 Tebbs RS, Zhao Y, Tucker JD, et al (1995), Thompson LH. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNArepair gene. Proc Natl Acad Sci USA, 92, 6354-8.   DOI   ScienceOn
19 Skjelbred CF, Saebo M, Wallin H, et al (2006). Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer, 16, 6-67.
20 Sun H, Qiao Y, Zhang X, et al (2010). XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci, 101, 1777-82.   DOI
21 Wang J, Zhao Y, Jiang J, et al (2010). Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. J Cancer Res Clin Oncol, 136, 1517-25.   DOI
22 Yeh CC, Sung FC, Tang R, et al (2005). Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer, 5, 12.   DOI
23 Zhou CP, Pan HZ, Li FX, et al (2014). Association analysis of colorectal cancer susceptibility variants with gastric cancer in a ChineseHan population. Genet Mol Res, 13, 3673-80.   DOI
24 Zhan P, Wang Q, Qian Q, Yu LK (2013). XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis. J Exp Clin Cancer Res, 32, 1.   DOI
25 Zhao Y, Deng X, Wang Z, et al (2012). Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 665-9.   DOI   ScienceOn
26 Canbay E, Cakmakoglu B, Zeybek U, Sozen S (2011). Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin, 27, 1295-302.   DOI   ScienceOn
27 Alanazi M, Pathan AA, Ajaj SA, et al (2013). DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia. Biol Res, 46, 161-7.   DOI
28 Arafa MA, Sallam S, Jriesat S, et al (2011). Colorectal cancer screening amongst first degree relatives of colon cancer cases in Jordan. Asian Pac J Cancer Prev, 12, 1007-11.
29 Bewick MA, Conlon MS, Lafrenie RM, et al (2006). Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol, 24, 5645-51.   DOI
30 Brenneman MA, Wagener BM, Miller CA, et al (2002). XRCC3 controls the fidelity of homologous recombination: roles for XRCC3 in late stages of recombination. Mol Cell, 10, 387-95.   DOI
31 Chen X, Wang Z, Yan Y, et al (2014). XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysi. PLoS One, 15, 84195.
32 Coory MD (2010). Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol, 39, 932-3.   DOI
33 Curtin K, Samowitz WS, Wolff RK, et al (2009). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking incolon cancer. Cancer Epidemiol Biomarkers Prev, 18, 3384-8.   DOI   ScienceOn
34 Fasching PA, Gayther S, Pearce L, et al (2009). Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol, 3,171-81.   DOI
35 Gil J, Ramsey D, Stembalska A, et al (2012). The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep, 39, 527-34.   DOI